Holen Sie sich die Stockscreener-App
0.6366
4.23%
-0.0281
Handel nachbörslich:
.63
-0.0066
-1.04%
Finanzdaten der Adaptimmune Therapeutics Plc Adr-Aktie (ADAP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
2,358%
5.678
|
0.231 | 7.319 | 5.13 | 47.60 |
Operating Expenses
|
9.69%
54.94
|
50.09 | 53.95 | 50.04 | 45.95 |
| Benefits Costs and Expenses |
9.94%
53.66
|
48.80 | 52.23 | 25.84 | 45.94 |
| Costs And Expenses |
9.69%
54.94
|
50.09 | 53.95 | 50.04 | 45.95 |
| Operating Income/Loss |
1.19%
-49.26
|
-49.86 | -46.63 | -44.91 | 1.656 |
| Income/Loss From Continuing Operations Before Tax |
1.23%
-47.98
|
-48.57 | -44.91 | -20.71 | 1.661 |
| Income Tax Expense/Benefit |
180.18%
0.526
|
-0.656 | 0.687 | 0.68 | 0.625 |
| Income/Loss From Continuing Operations After Tax |
1.22%
-48.50
|
-47.92 | -45.60 | -21.39 | 1.036 |
|
Net Income/Loss
|
1.22%
-48.50
|
-47.92 | -45.60 | -21.39 | 1.036 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
2,656%
1,451.24
|
52.65 | 1,357.85 | 1,108.17 | 991.33 |
| Diluted Average Shares |
2,656%
1,451.24
|
52.65 | 1,357.85 | 1,108.17 | 1,000.28 |
| Basic Earnings Per Share |
0.00%
-0.03
|
-0.03 | -0.03 | -0.02 | - |
| Diluted Earnings Per Share |
0.00%
-0.03
|
-0.03 | -0.03 | -0.02 | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.93%
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):